Evidence map›Paper›PMID 32245396›Full record

ArticleMilitary Medical Research2020

Updating the diagnostic criteria of COVID-19 "suspected case" and "confirmed case" is necessary.

Yun-Yun Wang, Ying-Hui Jin, Xue-Qun Ren, Yi-Rong Li, Xiao-Chun Zhang, Xian-Tao Zeng, Xing-Huan Wang, Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team

Open access · diamondAbstract readLetterComment
In one paragraph

Article in Military Medical Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
1.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. COVID-19 and Selenium Deficiency: a Systematic Review.Biological trace element research · 2022
    Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. COVID-19 versus SARS: A comparative review.Journal of infection and public health · 2021
    Review
  12. Article
  13. Article
  14. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2020
    Review
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yun-Yun WangCenter for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.
Ying-Hui JinCenter for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.
Xue-Qun RenInstitute of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, 475000, Henan, China.
Yi-Rong LiDepartment of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.
Xiao-Chun ZhangLeishenshan Hospital of Wuhan, Wuhan, 430200, Hubei, China.
Xian-Tao ZengCenter for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China. zengxiantao1128@163.com.
Xing-Huan WangCenter for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China. wangxinghuan1965@163.com.
Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team
Wuhan University · CNHenan University · CN

Funding

National Key Research and Development Program of China 2020YFC0845500Special Project for Emergency Science and Technology of Hubei Province 2020FCA008
6 · The paper itself

Abstract

On 6 February 2020, our team had published a rapid advice guideline for diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infection, and this guideline provided our experience and make well reference for fighting against this pandemic worldwide. However, the coronavirus disease 2019 (COVID-19) is a new disease, our awareness and knowledge are gradually increasing based on the ongoing research findings and clinical practice experience; hence, the strategies of diagnosis and treatment are also continually updated. In this letter, we answered one comment on our guideline and provided the newest diagnostic criteria of "suspected case" and "confirmed case" according to the latest Diagnosis and Treatment Guidelines for COVID-19 (seventh version) that issued by the National Health Committee of the People's Republic of China.

Indexed as

Coronavirus InfectionsPneumonia, ViralBetacoronavirusChinaCOVID-19HumansPandemicsSARS-CoV-22019-nCoVCOVID-19DiagnosisGuidelineNovel coronavirusPreventionSARS-CoV-2Treatment

Identifiers

PMID32245396
PMCPMC7125052
OpenAlexW3014786204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.